|
| health information | health factsheets
Anthrax
Anthrax is a naturally-occurring bacterium that rarely infects humans.
But with the recent attacks involving anthrax in the United States, we’ve
consulted the experts – at the Public Health Laboratory Service in the
UK, and the Centres for Disease Control and Prevention in America – to
develop some essential public information and advice.
What is anthrax?
Anthrax is an infectious disease caused
by a bacterium called Bacillus anthracis.
If exposed to air it can change into a
form known as a spore and that can last
for a long time (many generations) in
the environment e.g. the soil before
‘germinating’. It is carried by wild and
domestic animals in Asia, Africa and
parts of Europe.
What are the symptoms?
There are two main types of anthrax.
The cutaneous type starts as a skin
bump that ulcerates, which is not
generally a serious illness.
The second type, inhalational anthrax, is
normally less common and symptoms
begin as a flu-like illness which
progresses to pneumonia, respiratory
failure and sometimes septicaemia,
which can lead to shock and death.
There is a third type, intestinal anthrax, but this is a very
rare form of food poisoning and results
in fever and severe gut disease.
How is it spread and what is
the incubation period?
Cutaneous anthrax tends to occur
through direct contact with the skin or
tissues of infected animals. The early
stages of the lesion are noticed about three days from exposure, although the
incubation period can be 60 days.
Usually it is an occupational disease of
farmers, hide workers and people
working in the leather-making industry.
Inhalational anthrax usually occurs
about 2-3 days after exposure and the
outcome can be fatal within a futher
2-3 days. The spores can be inhaled
directly into the lungs.
Spores on food will contaminate it and
cause the intestinal form of the disease.
In times of famine people may eat
infected meat and this causes
the illness.
How contagious is
anthrax?
Normally 95 percent of anthrax cases are
cutaneous and are caused by direct
contact with abrasions on the skin.
Person to person infection is rare.
Despite the potential seriousness of the
inhalational type of anthrax, sufferers
do not produce a lot of large numbers
of infectious material to pass onto other
people (unlike for example, the flu
which is very contagious). This is
because the main lesions caused by
anthrax are not in the lung tissues,
where they produce material that could
be transmitted by coughing. Instead,
the rapid decline in health is caused by
toxins that are the by-product of the
activity of the bacterium.
There have been no known cases of
person-to-person spread of anthrax
pneumonia and it is not thought to be a
significant health risk. Therefore there is
no need to strictly quarantine patients
with anthrax and people who have
simply had contact with them do not
need treatment.
Is there a treatment?
The antibiotics ciprofloxacin,
doxycycline and penicillin can be given
in high doses to treat the condition.
Ciprofloxacin and doxycyline are also
used as prophylaxis (prevention) for
people who have been exposed. Early
treatment is needed if inhalational
anthrax is suspected.
Is there a vaccine?
There is an immunisation against
anthrax but it takes five doses of vaccine
over the course of a year to get
immunity. This makes immunisation too
slow to deal with accidental or
deliberate exposure. It is normally
offered to those who handle infected
animals, and laboratory staff who work
with the bacteria. It would be
recommended for a person who had
been exposed, in conjunction with
antibiotics, because of uncertainty
about when the spores may germinate.
The armed forces in the USA are
currently being given immunisation, but concerns have been expressed
about how safe, and effective, it is for
the general public.
In the UK, the Public Health Laboratory
Service controls supply of the vaccine.
Their advice, as of 15 October 2001, is
that immunisation is not recommended
pre-exposure to anyone except people
who are in the relevant occupational
groups mentioned above. PHLS is
monitoring the situation and will act
according to any outbreaks
or events.
Is there a test?
Swabs and smears can be taken from
infected exposed people and blood can
be analysed for the presence of
the bacteria.
What should ordinary
people do?
There is no need to take any specific
action. Increased understanding and
awareness are probably the best
defence. People who develop severe
unexplained fever with or without
vomiting, severe respiratory symptoms
and sudden flu-like symptoms such as
headaches and muscle pains should
contact their doctor.
|